USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ERGON PHARMACEUTICALS, LLC
Address:
ERGON PHARMACEUTICALS, LLC
620 MICHIGAN AVE, NE
DIST OF COL, DC 20064
Phone:
(301) 585-2703
URL:
N/A
EIN:
522177325
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $142,958.00 2

Award List:

"INVESTIGATION OF AN INEXPENIVE MOBILE BIOLOGICALLY ACTIVE AIR FILTRATION (BAF) UNIT FOR VOLATILE ORGANIC (VOC) COM- POUNDS"

Award Year / Program / Phase:
1987 / SBIR / Phase I
Award Amount:
$49,018.00
Agency:
EPA
Principal Investigator:
Dr h w cox
Abstract:
Increased emphasis on the problems associated with ing underground storage tanks and underground pollution in general has created a need for technology to reduce or elim-inate the associated contamination. to date, package air general has created a need for technology to reduce or eliminate the… More

A NOVEL ANTIANGIOGENIC TREATMENT

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$93,940.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Cancer is an important public health issue in US and worldwide. Every year, more than 1.2 million Americans are diagnosed with invasive carcinomas; half of them will eventually die from the diease or disease-related complications. These statistics make cancer the… More